Virtual tumor predicts response to liver cancer immunotherapy
Reported byMedicalXpress ↗·Sourced by Goodlede
Researchers from Johns Hopkins Kimmel Cancer Center developed a computational method to predict which patients with hepatocellular carcinoma will benefit from combination immunotherapy and targeted therapy, published July 14 in the Proceedings of the National Academy of Sciences.
Goodlede runs a two-pass source check on every story: one pass finds it, a second skeptical pass re-verifies the claim and writes what it doesn’t prove. This is a source check, not an independent fact-check — confirm anything important at the link above.
Read the full story at MedicalXpress
Read original story ↗More good news, verified daily.
Goodlede covers positive developments across science, nature, rights, and human achievement — verified before they appear. No hype, no roundups, no PR wires.
© 2026 Wag Media, LLC
More from Goodlede